Available In: Ghana, Nigeria, Kenya, Uganda, Tanzania, Rwanda, Mauritius, Madagascar,…
Reunion Islands, Zambia, South Africa, Lesotho, Botswana, Senegal, Tunisia, Morocco, Algeria, Egypt, Jordan, Saudi Arabia, Bahrain, Senegal, Tunisia, Pakistan, Turkey, Armenia, Kazakhstan, Azerbaijan, Oman,Turkmenistan, Uzbekistan, Tajikistan, Kyrgyzstan
Show more
Introducing the world’s most sensitive, fully automated immunoassay platform with multiplexing and custom assay
Up to 1000x greater sensitivity Up to 6 biomarkers in a single assay Compatible with 80+ assays
Unleashing the power of next-generation Simoa® Planar Array technology for robust multiplex biomarker detection – even at healthy baseline
• Up to 1000x greater sensitivity
• 10 biomarkers in a single assay
• Compatible with 100+ assays
Offers researchers access to ultra-sensitive biomarker detection capabilities in a compact and affordable system.
Up to 1000x greater sensitivity Up to 6 biomarkers in a single assay Compatible with 30+ assays
Measure biomarkers at lower levels than ever before
Neurology, Oncology, Inflammation/Immunology, Infectious diseases, Cardiology
Simoa, Quanterix’s cutting-edge digital health solution, heralds a new era in healthcare. By enabling the development of advanced methods for earlier disease detection, improved prognoses, and enhanced treatment strategies, it’s set to elevate both quality of life and longevity for future generations. Simoa transforms the study of health and disease biology, empowering researchers to meticulously analyze pivotal biomarkers across various therapeutic domains, spanning neurology, infectious diseases, oncology, inflammation, and cardiology
